An unusual case of sporadic Creutzfeld Jacob disease presenting as acute neuropathy
Objective: To describe an unusual case of sporadic Creutzfeld Jacob Disease (CJD) that initially presented with ascending tingling of lower extremities. Background: Prion diseases are…Preliminary results of 18F-DTBZ PET study in the patients with vascular parkinsonism
Objective: Our studies was designed to assess the dopaminergic pathway in the patients with vascular parkinsonism (VP). Background: VP develops as a consequence of heterogeneous…Presence of abnormalities on structural MRI associate with faster disease progression in multiple system atrophy
Objective: To identify MRI markers that are associated with more rapid clinical progression in multiple system atrophy (MSA) Background: The rate of clinical progression in…All-trans-retinoic Acid pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced hemi-parkinsonian rats
Objective: This study examined the effect of pretreatment with All-trans-retinoic Acid (ATRA) on the 6-hydroxydopamine-induced Parkinsonism in Wistar rats in order to find out whether…Curcumin I protect against copper induced neurobehavioral features of Parkinson’s disease in rat
Objective: evaluate the impact of acute Cu intoxication (10 mg/kg B.W. i.p) for 3 days on the dopaminergic system and locomotor performance, together with the…Relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT in patients with Parkinson’s disease
Objective: The objective of this study is to investigate a relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT SPECT (dopamine transporter (DAT) SPECT) in…Prospective longitudinal CSF measurements and cognitive decline in GBA-associated Parkinsonism: not Abeta or Tau but Lewy body pathology?
Objective: To evaluate whether concomitant Ab and Tau pathology might contribute to the prominent cognitive decline in PD_GBA. Background: A considerable proportion of idiopathic Parkinson’s…Subjective cognitive complaints in Parkinson’s disease patients: what should we value ?
Objective: Access the relation between subjective cognitive complaints (SCC) and objective cognitive impairment in Parkinson’s Disease (PD) patients with and without Dementia and evaluate the…Cerebrospinal fluid lysosomal enzymes and cognition in Parkinson’s disease
Objective: To evaluate cerebrospinal fluid (CSF) levels of lysosomal enzymes and assess their relationship with cognition in PD as potential early biomarkers of cognitive failure.…Information Content of Spoken Language in Parkinson’s Disease Without Dementia
Objective: Investigate differences in spoken language content in Parkinson’s disease (PD) compared to older controls. Background: Conveying information is a primary goal of communication. PD language…
- « Previous Page
- 1
- …
- 130
- 131
- 132
- 133
- 134
- …
- 155
- Next Page »